1. Home
  2. KALA

as 07-04-2025 10:34am EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Founded: 2009 Country:
United States
United States
Employees: N/A City: ARLINGTON
Market Cap: 26.2M IPO Year: 2017
Target Price: $14.00 AVG Volume (30 days): 71.3K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -7.62 EPS Growth: N/A
52 Week Low/High: $2.92 - $11.20 Next Earning Date: 08-05-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

KALA Daily Stock ML Predictions

Stock Insider Trading Activity of KALA BIO Inc. (KALA)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Iwicki Mark T KALA Director Jun 24 '25 Sell $4.01 13,227 $53,040.27 258,433
Bazemore Todd KALA SEE REMARKS Jun 24 '25 Sell $4.01 4,058 $16,272.58 83,699
Brazzell Romulus K KALA SEE REMARKS Jun 24 '25 Sell $4.01 5,251 $21,056.51 82,698
Reumuth Mary KALA CHIEF FINANCIAL OFFICER Jun 24 '25 Sell $4.01 3,631 $14,560.31 62,100
Iwicki Mark T KALA Director Jun 3 '25 Sell $3.74 21,732 $81,277.68 258,433
Bazemore Todd KALA SEE REMARKS Jun 3 '25 Sell $3.74 3,390 $12,678.60 83,699
Kharabi Darius KALA CHIEF BUSINESS OFFICER Jun 3 '25 Sell $3.74 730 $2,730.20 67,077
Brazzell Romulus K KALA SEE REMARKS Jun 3 '25 Sell $3.74 3,687 $13,789.38 82,698
Reumuth Mary KALA CHIEF FINANCIAL OFFICER Jun 3 '25 Sell $3.74 2,850 $10,659.00 62,100

Share on Social Networks: